A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants

Status:
COMPLETED

Trial end date:
2025-05-07

Target enrollment:

Participant gender:

This is an open label, fixed sequence, 1-way crossover drug-drug interaction (DDI) study in healthy participants.

PHASE1

Immunome, Inc.

Itraconazole